PMA · Approved
Recalled · Class II · 2014Protege GPS and Protege RX Carotid Stent Systems
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Medtronic Vascular, Inc. · NIM Stent, Carotid
Approved on Jan 24, 2007 through premarket approval, which rests on the device’s own clinical evidence after a 380-day review. It has been recalled 2 times.
- Decided
- Jan 24, 2007
- Review
- 380 days
- Class
- Class III
- Product code
- NIM
- Recalls
- 2
PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.
P060001 has 56 supplements since 2007: changes to the approved device, its labelling or its manufacturing, each approved separately.
PMA supplements approved per year
View FIG. 1 as a table
| Year | Supplements approved |
|---|---|
| 2007 | 3 |
| 2008 | 4 |
| 2010 | 3 |
| 2011 | 4 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 3 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 6 |
| 2025 | 8 |
| 2026 | 6 |
Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in NIM? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
Does it have a predicate?
PMA decisions do not claim a predicate device.
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
Recalls of this device
| Date | Class | Recall | Root cause | Reason |
|---|---|---|---|---|
| Dec 4, 2014 | Class II | Z-0878-2015 | Packaging process control | Two production lots of the Protege Rx Tapered Carotid Stent Systems (SECX-10-7-40-135, Lot # 9922452 & SEPX-8-6-40-135, Lot # 9922795) because of a product labeling error. |
| Dec 4, 2014 | Class II | Z-0879-2015 | Packaging process control | Two production lots of the Protege Rx Tapered Carotid Stent Systems (SECX-10-7-40-135, Lot # 9922452 & SEPX-8-6-40-135, Lot # 9922795) because of a product labeling error. |
No ancestor or descendant has a Class I recall.
How does its category compare?
All NIM devicesNIM Stent, Carotid: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.
FDA decisions per year · NIM
24in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · NIM
Too few NIM 510(k)s in any year since 2007 to give a median.
Recalls per year · NIM
7so far in 2026, the most since 2007
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · NIM
581in 2025
MAUDE reports naming product code NIM, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 24 | — | 1 | 493 |
| 2008 | 19 | — | 1 | 790 |
| 2009 | 12 | — | 3 | 961 |
| 2010 | 14 | — | 3 | 1,039 |
| 2011 | 17 | — | 0 | 720 |
| 2012 | 23 | — | 0 | 560 |
| 2013 | 14 | — | 0 | 469 |
| 2014 | 2 | — | 2 | 201 |
| 2015 | 11 | — | 0 | 127 |
| 2016 | 11 | — | 0 | 121 |
| 2017 | 8 | — | 0 | 133 |
| 2018 | 12 | — | 0 | 103 |
| 2019 | 11 | — | 1 | 181 |
| 2020 | 7 | — | 0 | 164 |
| 2021 | 13 | — | 0 | 202 |
| 2022 | 17 | — | 0 | 172 |
| 2023 | 14 | — | 0 | 172 |
| 2024 | 21 | — | 0 | 265 |
| 2025 | 24 | — | 1 | 581 |
| 2026 | 17 | — | 7 | — |
https://510kreport.com/device/P060001 · printed Nov 6, 2026
Cite this page
510(k) Report. “P060001: Protege GPS and Protege RX Carotid Stent Systems.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/P060001
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Page last updated Nov 3, 2026